Alejandra Matejic


En la cavidad bucal existe una situación única en nuestra biología: la irrupción del órgano dentario, que atraviesa los tejidos conectivo y epitelial creando una solución de continuidad y un serio riesgo para la salud.

Como contrapartida a la vulnerabilidad de esta área crítica, nuestro organismo ha desarrollado una serie de mecanismos de adaptación y defensa altamente efectiva. Aún así, en numerosas ocasiones, esta barrera resulta insuficiente y se establece una enfermedad destructiva crónica de los tejidos de soporte dental: la enfermedad periodontal o periodontitis.

La etiología primaria de la periodontitis está dada por el biofilm o biopelícula de placa bacteriana, cuya presencia desencadena mecanismos de inmunidad innata que actúan de forma inmediata e inducen una respuesta adaptativa específica.

Palabras clave

Enfermedad periodontal; diabetes

Texto completo:



Brown LJ., Oliver RC., Loe H. Periodontal disease in the US in 1981: prevalence, severity, extent and role in tooth mortality. J Periodontol. 1989; 60:363-370.

Brown LJ., Loe H. Prevalence, extent, severity and progression of periodontal disease. Periodontology 2000, 1993; 2:57-71.

Albandar JM. Underestimation of periodontitis in NHANES surveys. J Periodontol. 2011 Mar; 82 (3):337-341.

Socransky SS, Haffajee AD, Cugini MA, Smith C, Kent RL Jr. Microbial complexes in subgingival plaque. J Clin Periodontol. 1998; 25:134-144.

Krauss JL, Potempa J, Lambris JD, Hajishengallis G. Complementary Tolls in the periodontium: how periodontal bacteria modify complement an TLR responses to prevail in the host. Periodontology 2000. Vol. 52; 2010, 141-162.

Zelkha SA, Freilich RW, Amar S. Periodontal innate inmune mechanisms relevant to aterosclerosis and obesity. Periodontology 2000, Vol. 54, 2010: 207-221

Preshaw PM, Taylor JJ. How has research into cytokine interactions and their role in driving immune responses impacted our understanding of periodontitis? J Clin Periodontol. 2011; 38 Suppl 11:60-84.

Papapanou PN. World workshop in clinical periodontics. Periodontal diseases: Epidemiology. Ann Periodontol 1996; 1:1-36.

Tervonen T, Knuuttila M. Relation of diabetes control to periodontal pocketing and alveolar bone level. Oral Surg Oral Med Oral Pathol. 1986; 61:346-349.

Stewart JE, Wager KA, Friedlander AH, Zadeh HH. The effect of periodontal treatment on glycemic control in patients with type 2 diabetes mellitus. J Clin Periodontol. 2001; 28:306-310.

Grossi SG, Skrepcinski FB, DeCaro T, Robertson DC, Ho AW, Dunford RG, et al. Treatment of periodontal disease in diabetics reduces glycated hemoglobin. J Periodontol. 1997; 68:713-719.

Venza I, Visalli M, Cucinotta M, De Grazia G, Teti D, Venza M. Proinflamatory gene expression at chronic periodontitis and peri-implantitis sites in patients with or without type 2 diabetes. J Periodontol. Jan 2010; 81 (1):99-108.

Loos BG. Systemic markers of inflammation in periodontitis. J Periodontol. 2005; 76 (11 Suppl):2106-2115.

Nesse W, Linde A, Abbas F, Spijkervet FK, Dijkstra PU, de Branbander EC, Gerstenbluth I, Vissink A. Dose-response relationship between periodontal inflamed surface area and HbA1c in type 2 diabetics. J Clin Periodontol. 2009; 36:295-300.

Mealey BL. Periodontal disease and diabetes. A two-way street. J Am Dent Assoc. 2006 Oct; 137 Suppl:26-31.

Nishimura F, Iwamoto Y, Mineshiba J, Shimizu A, Soga Y, Murayama Y. Periodontal disease and diabetes mellitus: the role of tumor necrosis factor-alpha in a 2-way relationship. J Periodontol. 2003; 74:97-102.

Kim J, Amar S. Periodontal disease and systemic conditions: a bidirectional relationship. Odontology. 2006; 94:10-21.

Slots J. Casual or causal relationship between periodontal infection and non-oral disease? J Dent Res. 77 (10) 1998; 1764-1766.

Scannapieco FA. Position Paper. Periodontal disease as a potential risk factor for systemic diseases. J Periodontol. 1998; 69 (7): 841-850.

Williams RC, Barnett AH, Claffey N, Davis M, Gadsby R, Kellett M, Lip GY, Thackray S. The potential impact of periodontal disease on general health: a consensus view. Curr Med Res Opin 2008; 24:1635-1643.

Rose LF, Genco RJ, Cohen W, Mealey BL. Periodontal Medicine, 2000. B.C. Decker Inc.

Williams RC, Offenbacher S. Periodontal medicine: a new branch of periodontology. Periodontology 2000. 23; 2000, 9-12.

Williams RC. Periodontal disease: the emergence of a new paradigm. Compend Contin Educ Dent. Special Issue. 2001; 22 (2); 3-6.

Slots J, Kamma J. General health risk of periodontal disease. Int Den J 2001; 51:417-427.

Abhijit N Gurav. Periodontitis and Insulin Resistance: Casual or Causal Relationship? Diabetes Metab. J 2012; 36:404-411.

Shoelson SE, Lee J, Goldfine AB. Inflammation and insulin resistance. J Clin Invest. 2006; 116:1793-1801.

Vlassara H. Advanced glycation end-products and atherosclerosis. Ann Med. 1996 Oct; 28 (5): 419-426.

Lalla E., Lamster IB., Drury S., Fu C., Schmidt AM. Hyperglycemia, glycoxidation and receptor for advanced glycation endproducts: potential mechanisms underlying diabetic complications, including diabetes-associated periodontitis. Periodontology 2000, 2000, 23; 50-62.

Van Zoelen MA, Achouiti A, van der Poll T. RAGE during infectious diseases. Front Biosci (Schol Ed), 2011 Jun; 1 (3):1119-1132.

Nogueira-Machado JA, Volpe CM, Veloso CA, Chaves MM. HMGB1, TLR and RAGE: a functional tripod that leads to diabetic inflamation. Expert Opin Ther Targets 2011 Aug; 15 (8):1023-1035.

Lin L, Park S, Lakatta EG. RAGE signaling in inflammation and arterial aging. Front Biosci 2009 Jan; 1 (14):1403-1413.

Katz J, Wallet S, Cha S. Periodontal disease and the oral-systemic connection: “ Is it all the RAGE?”. Quintessence Int. 2010, 41; 3:229-237.

Yu S, Li H, Ma Y, Fu Y. Matrix metalloproteinase-1 of gingival fibroblasts influenced by AGEs and their association with receptor for AGEs and nuclear factor-kB in gingival connective tissue. J Periodontol. 2012, 83; 1: 119-126.

Lalla E, Lamster IB, Stern DM, Schmidt AM. Receptor for advanced glycation end products, inflammation and accelerated periodontal disease in diabetes: mechanisms and insights into therapeutic modalities. Ann Periodontol 2001; 6:113-118.

Jiang SY, Wei CC, Shang TT, Lian Q, Wu CX, Deng JY. High glucose induces inflammatory cytokine through protein kinase C-induced toll-like receptor 2 pathway in gingival fibroblasts. Biochem Biophys Res Commun. 2012 Oct 26; 427 (3):666-670.

Jun HK, Lee SH, Lee HR, Choi BK. Integrin a5b1 activates the NLRP3 inflammasome by direct interaction with a bacterial surface protein. Immunity, 2012 May 25; 36 (5):755-768.

Georgios N. Belibasakis, Anders Johansson. Aggregatibacter actinomycetemcomitans targets NLRP3 and NLRP6 inflammasome expression in human mononuclear leukocytes. Cytokine, 2012; 59:124-130.

Bostanci N, Meier A, Guggenheim B, Belibasakis GN. Regulation of NLRP3 and AIM2 inflammasome gene expression levels in gingival fibroblasts by oral biofilms. Celular Immunology, 2011; 270: 88-93.

Belibasakis GN, Guggenheim B, Bostanci N. Down-regulation of NLRP3 inflammasome in gingival fibroblasts by subgingival biofilms: Involvement of Porphyromonas gingivalis. Innate Immun. 2013 Feb; 19 (1):3-9.

Grant RW, Dixit VD. Mechanisms of disease: inflammasome activation and the development of type 2 diabetes. Front Immunol. 2013; 4:50.

Allen EM, Matthews JB, DJ OH, Griffiths HR, Chapple IL. Oxidative and inflammatory status in type 2 diabetes patients with periodontitis. J Clin Periodontol. 2011; 38:894-901.

Deshpande K, Jain A, Sharma R, Prashar S, Jain R. Diabetes and periodontitis. J Indian Soc Periodontol. 2010 Oct; 14 (4):207-212.

Manouchehr-Pour M., Spagnuolo PJ., Rodman HM., Bissada NF. Comparison of neutrophil chemotactic response in diabetic patients with mild and severe periodontal disease. J Periodontol. 1981 Aug; 52 (8):410-415.

Sakallioğlu EE, Ayas B, Lütfioğlu M, Keleş GC, Açikgöz G, Firatli E. Gingival levels of monocyte chemoattractant protein-1 (MCP-1) in diabetes mellitus and periodontitis: an experimental study in rats. Clin Oral Investig. 2008 Mar; 12(1):83-9.

Gupta M, Chaturvedi R, Jain A. Role of monocyte chemoattractant protein-1 (MCP-1) as an immune-diagnostic biomarker in the pathogenesis of chronic periodontal disease. Cytokine. 2013 Mar; 61 (3):892-7.

Salvi GE, Carollo-Bittel B, Lang NP. Effects of diabetes mellitus on periodontal and peri-implant conditions. Update on associations and risks. J Clin Periodontol. 2008; 35 (Suppl.8): 398-409.

Salvi GE, Beck JD, Offenbacher S. PGE2, IL-1 β and TNFα responses in diabetics as modifiers of periodontal disease expression. Ann Periodontol. 1998 Jul; 3 (1):40-50.

Rees TD. Periodontal management of the patient with diabetes mellitus. Periodontology 2000, 2000; 23:63-72.

Haffajee AD, Socransky SS, Gunsolley JC Systemic anti-infective periodontal therapy. A systematic review. Ann Periodontol. 2003 Dec; 8 (1):115-181.

Guerrero A, Griffiths GS, Nibali L, Suvan J, Moles DR, Laurell L, Tonetti MS. Adjunctive benefits of systemic amoxicillin and metronidazole in non-surgical treatment of generalized aggressive periodontitis: a randomized placebo-controlled clinical trial. J Clin Periodontol. 2005 Oct; 32 (10):1096-1107.

Winkel EG, Van Winkelhoff AJ, Timmerman MF, Van der Velden U, Van der Weijden GA Amoxicillin plus metronidazole in the treatment of adult periodontitis patients. A double-blind placebo-controlled study. J Clin Periodontol. 2001 Apr; 28 (4):296-305.

Rifkin BR, Vernillo AT, Golub LM. Blocking periodontal disease progression by inhibiting tissue-destructive enzimes: a potential therapeutic role for tetracyclines and their chemically-modified analogs. J Periodontol. 1993 Aug; 64 (8 Suppl):819-827.

Grossi SG, Skrepcinski FB, De Caro T, Robertson DC, Ho AW, Dunford RG, et al. Treatment of periodontal disease in diabetics reduces glycated hemoglobin. J Periodontol. 1997; 68:713-9.

Grossi SG, Skrepcinski FB, DeCaro T, Zambon JJ, Cummins D, Genco RJ. Response to periodontal therapy in diabetics and smokers. J Periodontol. 1996 Oct; 67(10 Suppl):1094-1102.

Serrano C, Pérez C, Sabogal D Effect of periodontal therapy on metabolic control and an inflammatory mediator in type 2 diabetic subjects: a report on 17 consecutive cases. J Int Acad Periodontol. 2012 Apr; 14 (2):26-34

Tervonen T Knuuttila M, Pohjamo L, Nurkkala H. Immediate response to non-surgical periodontal treatment in subjects with diabetes mellitus. J Clin Periodontol. 1991 Jan; 18 (1): 65-68.

Westfelt E, Rylander H, Blohmé G, Jonasson P, Lindhe J. The effect of periodontal therapy in diabetics. Results after 5 years. J Clin Periodontol. 1996 Feb; 23 (2):92-100.

Karialainen KM, Knuuttila ML, Von Dickhoff KJ. Association of the severity of periodontal disease with organ complications in type 1 diabetic patients. J Periodontol. 1994 Nov; 65 (11):1067-1072.

Chen L, Wei B, Li J, Liu F, Xuan D, Xie B, Zhang J. Association of periodontal parameters with metabolic level and systemic inflammatory markers in patients with type 2 diabetes. J Periodontol. 2010 March; 81 (3):364-371.

Saito T, Shimazaki Y, Kiyohara Y, Kato I, Kubo M, Iida M, Koga T. The severity of periodontal disease is associated with the development of glucose intolerance in non-diabetics: the Hisayama study. J Dent Res. 2004 Jun; 83 (6):485-490.

Donahue RP, Wu T. Insulin resistance and periodontal disease: an epidemiologic overview of research needs and future directions. Ann Periodontol 2001; 6: 119-124.


Copyright (c) 2020 Sociedad Argentina de Diabetes Asociación Civil